Immunity (HBV)

Anti-HBc Does Not Preclude Hepatitis B Vaccination

Published in Hepatitis Weekly, May 11th, 1998

People with antibody to hepatitis B core antigen may still benefit from vaccination against hepatitis B virus (HBV).

Researchers from the U.S. National Institutes of Health Hepatitis Studies Section found that having antibody to hepatitis B core antigen (anti-HBc) is not an accurate single marker of HBV infection.

"When a person who is screened for hepatitis B vaccination by enzyme immunoassay (EIA) is found to have isolated anti-HBc in their serum, the most practical approach would be to offer the person the hepatitis B vaccine and evaluate their response to vaccination," A. Eduardo Silva and colleagues wrote ("Hepatitis B Virus DNA in Persons with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1998-05-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry